These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 10909418)

  • 1. Therapeutic angiogenesis for ischemic syndromes.
    Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY
    Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
    J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
    Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
    Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor].
    Zaric V; Weltin D; Stephan D
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
    Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
    Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
    Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
    FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
    Mack CA; Magovern CJ; Budenbender KT; Patel SR; Schwarz EA; Zanzonico P; Ferris B; Sanborn T; Isom P; Ferris B; Sanborn T; Isom OW; Crystal RG; Rosengart TK
    J Vasc Surg; 1998 Apr; 27(4):699-709. PubMed ID: 9576084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
    Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
    J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
    Gowdak LH; Poliakova L; Li Z; Grove R; Lakatta EG; Talan M
    J Vasc Surg; 2000 Aug; 32(2):343-52. PubMed ID: 10917995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
    Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
    Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
    Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.